24 Participants Needed

Augmented Reality for Loneliness

KJ
Overseen ByKelley J. Colopietro, BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Vanderbilt University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment 2-D AV, HMD AR for loneliness?

Research suggests that Virtual Reality (VR), which is similar to Augmented Reality (AR), can help reduce loneliness by creating spaces for group activities, rather than just passive content consumption. This approach has been explored in older adults, indicating potential benefits for loneliness reduction.12345

Is augmented reality safe for reducing loneliness?

The research does not provide specific safety data for augmented reality in reducing loneliness, but it highlights the importance of careful design and guidelines to prevent potential issues.36789

How does the Augmented Reality treatment for loneliness differ from other treatments?

The Augmented Reality treatment for loneliness is unique because it uses immersive technology to create interactive social experiences, which can help reduce feelings of loneliness by facilitating group activities and enhancing social connections, unlike traditional methods that may not offer such engaging and interactive environments.36101112

What is the purpose of this trial?

The goal of this clinical trial is to test the use of head-mounted display (HMD) augmented reality (AR) in older adults residing in long term care communities. The main questions it aims to answer are: what is the feasibility, acceptability, and satisfaction of HMD AR vs two-dimensional audio-video communication? Older adults and their designated family member will complete HMD AR activities in 8 session visits over 4 weeks. Researchers will compare HMD AR to 2-D audio-visual (AV) comparison group on feasibility, acceptability, and satisfaction with the interactive communication technology.

Research Team

NS

Nilanjan Sarkar

Principal Investigator

Vanderbilt University

Eligibility Criteria

This trial is for older adults aged 60 or above who have been living in long-term care facilities for more than three months. Participants must be able to give consent and understand English. Those with physical impairments that prevent participation or those who are terminally ill cannot join.

Inclusion Criteria

Residing at LTC greater than 3 months
I am 60 years old or older.

Exclusion Criteria

I have a physical condition that prevents me from joining.
Terminally ill
I am unable to understand or sign the consent form.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in collaborative activities using HMD AR or 2-D Audio-Visual technology in 8 sessions over 4 weeks

4 weeks
8 session visits

Follow-up

Participants are monitored for feasibility, acceptability, and satisfaction of the intervention

4 weeks

Treatment Details

Interventions

  • 2-D AV
  • HMD AR
Trial Overview The study is examining the effectiveness of using head-mounted display augmented reality (HMD AR) versus traditional two-dimensional audio-video (2-D AV) communication to reduce loneliness in older adults. It involves 8 sessions over 4 weeks, assessing feasibility, acceptability, and satisfaction.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: HMD ARExperimental Treatment1 Intervention
Pairs of older adults with their designated family members who geographically apart will perform collaborative activities using HMD AR in 8 sessions over 4 weeks.
Group II: 2-D Audio-VisualActive Control1 Intervention
Pairs of older adults with their designated family members who geographically apart will perform collaborative activities using 2-D Audio-Visual in 8 sessions over 4 weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt University

Lead Sponsor

Trials
714
Recruited
6,143,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The UCLA Loneliness Scale is a newly developed, reliable 20-item tool for assessing loneliness, demonstrating high internal consistency (coefficient alpha = .96) and good stability over time (test-retest correlation of .73 over two months).
The scale shows strong concurrent and preliminary construct validity, correlating well with self-reported loneliness and related emotional states, as well as with participation in a 'loneliness clinic.'
Developing a measure of loneliness.Russell, D., Peplau, LA., Ferguson, ML.[2022]
Patients with coronary heart disease prefer loneliness reduction interventions that align with their social norms and involve their social network members.
The design of such interventions should be tailored to individual preferences, considering factors like existing relationships, the need for mental energy, and the structure and timing of the intervention.
One size does not fit all: A qualitative study exploring preferences and barriers towards the design of a loneliness reduction intervention in patients with coronary heart disease.Blakoe, M., Berg, SK., Højskov, IE., et al.[2022]
Virtual Reality (VR) has potential as a rehabilitation tool for older adults, particularly in addressing cognitive decline and loneliness, as explored through workshops with 25 participants over 6 months.
The study emphasizes the importance of designing VR experiences that promote group activities rather than passive content consumption, suggesting that this approach can help reduce feelings of loneliness among older adults.
Tackling Loneliness and Isolation in Older Adults With Virtual Reality: How do We Move Forward?Finnegan, DJ., Campbell, S.[2023]

References

Developing a measure of loneliness. [2022]
One size does not fit all: A qualitative study exploring preferences and barriers towards the design of a loneliness reduction intervention in patients with coronary heart disease. [2022]
Tackling Loneliness and Isolation in Older Adults With Virtual Reality: How do We Move Forward? [2023]
Validation of the ALONE Scale: A Clinical Measure of Loneliness. [2022]
Friends from the Future: A Scoping Review of Research into Robots and Computer Agents to Combat Loneliness in Older People. [2022]
Social virtual reality helps to reduce feelings of loneliness and social anxiety during the Covid-19 pandemic. [2023]
Facilitators and barriers to using virtual reality and augmented reality and its impact on social engagement in aged care settings: a scoping review protocol. [2022]
Identifying Behavioral Phenotypes of Loneliness and Social Isolation with Passive Sensing: Statistical Analysis, Data Mining and Machine Learning of Smartphone and Fitbit Data. [2020]
Understanding the psychological experiences of loneliness in later life: qualitative protocol to inform technology development. [2023]
Understanding Loneliness in Younger People: Review of the Opportunities and Challenges for Loneliness Interventions. [2023]
Can technology impact loneliness in dementia? A scoping review on the role of assistive technologies in delivering psychosocial interventions in long-term care. [2023]
Managing Perceived Loneliness and Social-Isolation Levels for Older Adults: A Survey with Focus on Wearables-Based Solutions. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security